Freudenberg Medical names new CEO

BEVERLY, Mass.—Max Kley, who has been at the helm of Freudenberg Medical since August 2016, is taking on a new role with the company and turning over the reins of Freudenberg Medical in the process.

Mark Ostwald will succeed Kley as Freudenberg Medical CEO. Kley is poised to take on a new role as CEO of the newly established Freudenberg business group for the battery and fuel cell market.

"Mark is the ideal candidate to lead Freudenberg Medical into the next phase of rapid growth and global expansion," Kley said in a statement. "His strong focus on customer needs, his experience in the medical device industry and his international background ensure that Freudenberg Medical will continue to be a driving force for innovation and quality in the global medical device and pharmaceutical industries."

Ostwald, who joined Freudenberg Medical in 2009, most recently served as Freudenberg Medical's chief technical officer and as part of the management board. His other leadership roles include president of Europe and head of minimally invasive solutions and vice president and general manager of the silicones business unit in California. Ostwald also helped to establish the Kaiserslautern, Germany, operation as managing director of Freudenberg Medical Europe.

"I am honored to lead the company at this exciting time of growth," Ostwald said in a statement. "Freudenberg Medical is a great company with innovation at its core. Working with our talented team we will continue to push the envelope with new products and innovative technology to advance health care manufacturing and drive value for our customers."